Antiparasitics

Protozoa, worms and external parasites

Protozoa are single-celled organisms, whereas helminths are parasitic worms. Ectoparasites live on the body surface or within superficial layers. These biological distinctions help explain ATC groups including antiprotozoals, anthelmintics and ectoparasiticides. The word parasite therefore establishes neither one anatomical site nor a common medicine mechanism. Bacteria, viruses and fungi form other categories of agents and are not absorbed into these families merely because the word infection also applies. Understanding the target organism gives the category a clearer pharmaceutical scope.

Distinct pharmaceutical fields

Antimalarials illustrate part of the antiprotozoal field, while worm medicines relate to helminths. Scabies provides another setting, with medicines that can use different administration routes. These examples clarify terminology without establishing a list of available treatments or an automatic match between symptoms and products. Selected substances have several documented indications and functions depending on the molecule and presentation. Intended purpose must consequently be read together with substance, presentation and official information, rather than inferred from a broad family name or a familiar infectious disease term.

Local and systemic forms

Cutaneous preparations and oral forms have different pharmaceutical characteristics. A lotion is not another expression for a tablet, and a concentration cannot be directly compared with content per solid unit. The wider external-parasite environment can also contain products of several regulatory statuses, including repellents. This medicinal category does not turn every such product into a medicinal product. In pharmacy practice, target parasite, route, formulation and status provide more precise distinctions than a general antiparasitic description and avoid implying equivalence between preparations with different sites or purposes.

Frequently asked questions